PDS Biotech receives broad Japanese patent for lead candidate PDS0101

PDS Biotechnology Corp

Japan Patent Office issued Patent No. 7783866 for PDS0101 covering broad composition of matter and methods of use.
Patent expands PDS Biotech's IP portfolio in Japan; previously granted patents in US, China, Australia, Hong Kong.
Company anticipates patent and market protections for PDS0101 into the 2040s, including US biologics exclusivity.
PDS0101 is in Phase 3 trial for HPV16-positive recurrent/metastatic head and neck cancer.
CEO Frank Bedu-Addo stated the patent strengthens global IP and supports growth.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.